4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-007693
Chief Executive Officer sold 16,122 shares at $9.45 ($152,408)
- Chief Executive Officer acquired 240,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| De Backer Marianne Chief Executive Officer | 2025-02-22 | Grant or award 10b5-1 | +240,000 | 865,339 | D | ||
| De Backer Marianne Chief Executive Officer | 2025-02-24 | Sale 10b5-1 | −16,122 | $9.45 | $152,408 | 849,217 | D |
| Derivatives | |||||||
| De Backer Marianne Chief Executive Officer | 2025-02-22 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +480,000 | 480,000 | D | ||
| Open-market sales · 16,122 sh · avg $9.45 · $152,408 | |||||||
Loading xslF345X05/wk-form4_1740515751.xml…